| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 8.90e-06 | 20 | 135 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.95e-05 | 36 | 135 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RALGAPA1 RANBP2 TBC1D15 RASGRF1 MYO9A CYTH1 DOCK9 RGPD1 RGS2 RGPD3 RPGR | 1.73e-04 | 507 | 135 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RALGAPA1 RANBP2 TBC1D15 RASGRF1 MYO9A CYTH1 DOCK9 RGPD1 RGS2 RGPD3 RPGR | 1.73e-04 | 507 | 135 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | translation elongation factor activity | 3.17e-04 | 20 | 135 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.62e-04 | 50 | 135 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR KIF13B KLHL2 KIF6 PSG5 MYO9A ARPC1A GC SAXO1 EPB41L4A RGS2 KPTN ALMS1 LMO7 TLN1 ANKRD1 SYNE2 MACF1 | 4.40e-04 | 1099 | 135 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.53e-04 | 53 | 135 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.30e-04 | 279 | 135 | 8 | GO:0005096 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.22e-07 | 9 | 136 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.68e-07 | 10 | 136 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | positive regulation of translational termination | 1.12e-06 | 4 | 136 | 3 | GO:0045905 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.23e-06 | 13 | 136 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.72e-06 | 14 | 136 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | positive regulation of translational elongation | 2.78e-06 | 5 | 136 | 3 | GO:0045901 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 8.07e-06 | 20 | 136 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of translational termination | 2.29e-05 | 9 | 136 | 3 | GO:0006449 | |
| GeneOntologyBiologicalProcess | regulation of translational elongation | 9.68e-05 | 14 | 136 | 3 | GO:0006448 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.12e-04 | 38 | 136 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | mesodermal to mesenchymal transition involved in gastrulation | 1.29e-04 | 3 | 136 | 2 | GO:0060809 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell polarity | 1.67e-04 | 42 | 136 | 4 | GO:0090162 | |
| GeneOntologyBiologicalProcess | translational termination | 1.78e-04 | 17 | 136 | 3 | GO:0006415 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.95e-10 | 14 | 136 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 8.67e-08 | 18 | 136 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.18e-07 | 8 | 136 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.55e-07 | 20 | 136 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.49e-07 | 10 | 136 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | inclusion body | 2.01e-06 | 90 | 136 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 4.37e-06 | 101 | 136 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 9.41e-06 | 21 | 136 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 TPR SETD1A SIN3B RANBP2 AFF2 AFF3 RGPD1 XRCC1 KMT2E BOD1L2 INO80D IRF9 EIF5AL1 RGPD3 SYNE2 EIF5A SMARCD1 SMARCD2 SMARCD3 BOD1L1 HNRNPR | 7.91e-05 | 1377 | 136 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | brahma complex | 9.30e-05 | 14 | 136 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | inhibin-betaglycan-ActRII complex | 1.26e-04 | 3 | 136 | 2 | GO:0034673 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 1.42e-04 | 16 | 136 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | super elongation complex | 6.20e-04 | 6 | 136 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 8.64e-04 | 7 | 136 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 9.62e-04 | 30 | 136 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 TPR RANBP2 RGPD1 CLCC1 EIF5AL1 RIF1 LMO7 RGPD3 SYNE2 EIF5A | 1.10e-03 | 560 | 136 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | ciliary basal body | 1.76e-03 | 195 | 136 | 6 | GO:0036064 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.06e-03 | 349 | 136 | 8 | GO:0031965 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 7.08e-06 | 16 | 114 | 4 | MP:0003701 | |
| MousePheno | abnormal rod electrophysiology | 5.26e-05 | 119 | 114 | 7 | MP:0004021 | |
| MousePheno | abnormal morula morphology | 5.46e-05 | 26 | 114 | 4 | MP:0012058 | |
| Domain | IF5A_HYPUSINE | 3.95e-07 | 3 | 138 | 3 | PS00302 | |
| Domain | Transl_elong_IF5A_C | 3.95e-07 | 3 | 138 | 3 | IPR020189 | |
| Domain | Transl_elong_IF5A | 3.95e-07 | 3 | 138 | 3 | IPR001884 | |
| Domain | eIF-5a | 3.95e-07 | 3 | 138 | 3 | PF01287 | |
| Domain | SWIB_domain | 3.95e-07 | 3 | 138 | 3 | IPR019835 | |
| Domain | SWIB | 3.95e-07 | 3 | 138 | 3 | SM00151 | |
| Domain | Trans_elong_IF5A_hypusine_site | 3.95e-07 | 3 | 138 | 3 | IPR019769 | |
| Domain | eIF-5a | 3.95e-07 | 3 | 138 | 3 | SM01376 | |
| Domain | Ran_BP1 | 1.35e-06 | 12 | 138 | 4 | PF00638 | |
| Domain | RANBD1 | 1.35e-06 | 12 | 138 | 4 | PS50196 | |
| Domain | RanBD | 1.94e-06 | 13 | 138 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 1.94e-06 | 13 | 138 | 4 | IPR000156 | |
| Domain | SWIB | 3.90e-06 | 5 | 138 | 3 | PF02201 | |
| Domain | - | 7.77e-06 | 6 | 138 | 3 | 1.10.245.10 | |
| Domain | SWIB_MDM2_domain | 7.77e-06 | 6 | 138 | 3 | IPR003121 | |
| Domain | Rab_bind | 1.35e-05 | 7 | 138 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.35e-05 | 7 | 138 | 3 | IPR032023 | |
| Domain | - | 4.56e-05 | 10 | 138 | 3 | 1.10.220.60 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 5.42e-05 | 2 | 138 | 2 | IPR013037 | |
| Domain | - | 5.42e-05 | 2 | 138 | 2 | 2.60.40.1150 | |
| Domain | Grip | 6.24e-05 | 11 | 138 | 3 | SM00755 | |
| Domain | GRIP | 6.24e-05 | 11 | 138 | 3 | PF01465 | |
| Domain | GRIP_dom | 8.27e-05 | 12 | 138 | 3 | IPR000237 | |
| Domain | GRIP | 8.27e-05 | 12 | 138 | 3 | PS50913 | |
| Domain | TPR-contain_dom | 1.26e-04 | 150 | 138 | 7 | IPR013026 | |
| Domain | Bod1-like | 1.62e-04 | 3 | 138 | 2 | IPR026955 | |
| Domain | AP_complex_bsu_1_2_4 | 1.62e-04 | 3 | 138 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.62e-04 | 3 | 138 | 2 | PF09066 | |
| Domain | TPR_REGION | 2.27e-04 | 165 | 138 | 7 | PS50293 | |
| Domain | TPR | 2.27e-04 | 165 | 138 | 7 | PS50005 | |
| Domain | Translation_prot_SH3-like | 2.49e-04 | 17 | 138 | 3 | IPR008991 | |
| Domain | Rib_L2_dom2 | 2.97e-04 | 18 | 138 | 3 | IPR014722 | |
| Domain | - | 2.97e-04 | 18 | 138 | 3 | 2.30.30.30 | |
| Domain | PP1_inhibitor | 3.22e-04 | 4 | 138 | 2 | IPR008025 | |
| Domain | - | 3.22e-04 | 4 | 138 | 2 | 1.10.150.220 | |
| Domain | B2-adapt-app_C | 3.22e-04 | 4 | 138 | 2 | SM01020 | |
| Domain | TF_AF4/FMR2 | 3.22e-04 | 4 | 138 | 2 | IPR007797 | |
| Domain | B-adaptin_app_sub_C | 3.22e-04 | 4 | 138 | 2 | IPR015151 | |
| Domain | PP1_inhibitor | 3.22e-04 | 4 | 138 | 2 | PF05361 | |
| Domain | AF-4 | 3.22e-04 | 4 | 138 | 2 | PF05110 | |
| Domain | TPR | 3.94e-04 | 129 | 138 | 6 | SM00028 | |
| Domain | TPR_repeat | 4.64e-04 | 133 | 138 | 6 | IPR019734 | |
| Domain | AP_beta | 5.34e-04 | 5 | 138 | 2 | IPR026739 | |
| Domain | Beta2_adaptin/TBP_C_dom | 7.97e-04 | 6 | 138 | 2 | IPR012295 | |
| Domain | - | 7.97e-04 | 6 | 138 | 2 | 3.30.310.10 | |
| Domain | ARM-type_fold | 9.49e-04 | 339 | 138 | 9 | IPR016024 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RASGRF1 CYTH1 DOCK9 RGPD1 EPB41L4A WDFY4 TLN1 RGPD3 | 1.27e-03 | 426 | 138 | 10 | IPR011993 |
| Domain | - | 1.33e-03 | 222 | 138 | 7 | 1.25.10.10 | |
| Domain | CH | 1.36e-03 | 65 | 138 | 4 | SM00033 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.47e-03 | 8 | 138 | 2 | IPR009028 | |
| Domain | TPR-like_helical_dom | 1.75e-03 | 233 | 138 | 7 | IPR011990 | |
| Domain | CH | 1.79e-03 | 70 | 138 | 4 | PF00307 | |
| Domain | HTH_MYB | 1.89e-03 | 9 | 138 | 2 | PS51294 | |
| Domain | Alpha_adaptinC2 | 1.89e-03 | 9 | 138 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.89e-03 | 9 | 138 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.89e-03 | 9 | 138 | 2 | SM00809 | |
| Domain | Myb_dom | 1.89e-03 | 9 | 138 | 2 | IPR017930 | |
| Domain | - | 1.89e-03 | 71 | 138 | 4 | 1.10.418.10 | |
| Domain | CH | 2.09e-03 | 73 | 138 | 4 | PS50021 | |
| Domain | CH-domain | 2.31e-03 | 75 | 138 | 4 | IPR001715 | |
| Domain | CAP_GLY | 2.35e-03 | 10 | 138 | 2 | PF01302 | |
| Domain | CAP_GLY | 2.35e-03 | 10 | 138 | 2 | SM01052 | |
| Domain | - | 2.35e-03 | 10 | 138 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 2.35e-03 | 10 | 138 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 2.35e-03 | 10 | 138 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 2.35e-03 | 10 | 138 | 2 | IPR000938 | |
| Domain | - | 2.52e-03 | 391 | 138 | 9 | 2.30.29.30 | |
| Domain | KOW | 2.85e-03 | 11 | 138 | 2 | IPR005824 | |
| Domain | KOW | 2.85e-03 | 11 | 138 | 2 | PF00467 | |
| Domain | ARM | 3.19e-03 | 40 | 138 | 3 | SM00185 | |
| Domain | Laminin_G_2 | 3.19e-03 | 40 | 138 | 3 | PF02210 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.41e-03 | 12 | 138 | 2 | IPR013041 | |
| Pathway | REACTOME_HYPUSINE_SYNTHESIS_FROM_EIF5A_LYSINE | 4.57e-06 | 5 | 110 | 3 | MM14823 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.73e-06 | 58 | 110 | 6 | MM14736 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 9.87e-06 | 18 | 110 | 4 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.40e-05 | 40 | 110 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.58e-05 | 41 | 110 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.78e-05 | 42 | 110 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.01e-05 | 43 | 110 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.12e-05 | 47 | 110 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.83e-05 | 49 | 110 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.23e-05 | 50 | 110 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.66e-05 | 51 | 110 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.73e-05 | 55 | 110 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.70e-05 | 58 | 110 | 5 | MM15149 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.50e-04 | 65 | 110 | 5 | MM15147 | |
| Pathway | WP_GLUCOCORTICOID_RECEPTOR_PATHWAY | 2.13e-04 | 70 | 110 | 5 | M40042 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.60e-04 | 73 | 110 | 5 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 4.47e-04 | 82 | 110 | 5 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.99e-04 | 84 | 110 | 5 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 5.57e-04 | 86 | 110 | 5 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.57e-04 | 92 | 110 | 5 | MM14951 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 8.38e-04 | 254 | 110 | 8 | M27131 | |
| Pubmed | CYLD SETD1A SIN3B XRN2 ZNF607 BCORL1 RGPD1 XRCC1 LARP4 INO80D ZBTB14 IRF9 RIF1 FAT1 FBN1 ZZZ3 ALMS1 SYNE2 ZSCAN18 SMARCD1 SMARCD2 PDS5A SMARCD3 ZFR PSME3 SPEN TRAPPC9 FOXI1 HNRNPR | 4.16e-13 | 1429 | 139 | 29 | 35140242 | |
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 8.47e-09 | 7 | 139 | 4 | 11353387 | |
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 30944974 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 8.47e-09 | 7 | 139 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 8.47e-09 | 7 | 139 | 4 | 17372272 | |
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 38657106 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 21205196 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 18949001 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 25187515 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 8603673 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 26632511 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 24403063 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 23818861 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 23536549 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 12191015 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 22821000 | ||
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.69e-08 | 8 | 139 | 4 | 21670213 | |
| Pubmed | 1.69e-08 | 8 | 139 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.69e-08 | 8 | 139 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.69e-08 | 8 | 139 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.69e-08 | 8 | 139 | 4 | 28745977 | |
| Pubmed | 2.36e-08 | 22 | 139 | 5 | 27717094 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 3.03e-08 | 9 | 139 | 4 | 18394993 | |
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 28100513 | ||
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 17887960 | ||
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 11553612 | ||
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 10601307 | ||
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 9733766 | ||
| Pubmed | 3.03e-08 | 9 | 139 | 4 | 28877029 | ||
| Pubmed | 5.04e-08 | 10 | 139 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 5.04e-08 | 10 | 139 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 5.04e-08 | 10 | 139 | 4 | 8857542 | |
| Pubmed | 5.04e-08 | 10 | 139 | 4 | 21859863 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 11161802 | ||
| Pubmed | Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice. | 6.25e-08 | 3 | 139 | 3 | 27125315 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 36848144 | ||
| Pubmed | Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. | 6.25e-08 | 3 | 139 | 3 | 16519677 | |
| Pubmed | 7.89e-08 | 11 | 139 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 7.89e-08 | 11 | 139 | 4 | 35771867 | |
| Pubmed | 7.89e-08 | 11 | 139 | 4 | 34110283 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD KIF13B XRN2 MYO9A BCORL1 RTN3 EIF5AL1 ZZZ3 ALMS1 LMO7 MACF1 SPEN TOP3A HNRNPR | 1.13e-07 | 588 | 139 | 14 | 38580884 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.70e-07 | 13 | 139 | 4 | 31427429 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A RANBP2 BCORL1 RGPD1 ZBTB14 ZZZ3 ALMS1 SMARCD1 SMARCD2 SMARCD3 SPEN | 1.87e-07 | 351 | 139 | 11 | 38297188 |
| Pubmed | 3.22e-07 | 15 | 139 | 4 | 14697343 | ||
| Pubmed | 3.35e-07 | 225 | 139 | 9 | 12168954 | ||
| Pubmed | TPR SETD1A SIN3B TBC1D15 ZZZ3 ALMS1 LMO7 TLN1 ZFR BOD1L1 PSME3 PARD3 SPEN | 3.49e-07 | 549 | 139 | 13 | 38280479 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 4.28e-07 | 38 | 139 | 5 | 12791264 | |
| Pubmed | FNBP1 SIN3B RANBP2 XRN2 BCORL1 XRCC1 INO80D ERGIC3 AP1B1 AP2B1 TLN1 SMARCD1 SMARCD2 PDS5A ZFR PSME3 SPEN HNRNPR | 4.59e-07 | 1103 | 139 | 18 | 34189442 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 9693044 | ||
| Pubmed | Biological Relevance and Therapeutic Potential of the Hypusine Modification System. | 6.21e-07 | 5 | 139 | 3 | 26037925 | |
| Pubmed | RANBP2 DOCK9 KMT2E PGM1 ALMS1 TLN1 ANKRD1 SYNE2 MACF1 PSME3 PARD3 HNRNPR | 8.21e-07 | 497 | 139 | 12 | 23414517 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TPR KLHL2 RANBP2 RGPD1 FBXO30 AP2B1 TLN1 RGPD3 EIF5A SMARCD1 SMARCD2 PDS5A ZFR VPS28 TOP3A MYBL1 HNRNPR | 8.88e-07 | 1155 | 139 | 18 | 20360068 |
| Pubmed | TPR FNBP1 RANBP2 TBC1D15 XRN2 ANKLE2 PPP1R14B RIF1 LMO7 NAV2 SMARCD2 SPEN | 9.31e-07 | 503 | 139 | 12 | 16964243 | |
| Pubmed | TPR FBXO30 RIF1 ZZZ3 LMO7 TLN1 EIF5A SMARCD1 SMARCD2 ZFR BOD1L1 PSME3 | 9.91e-07 | 506 | 139 | 12 | 30890647 | |
| Pubmed | RGPD4 TPR SIN3B RANBP2 TBC1D15 BCORL1 RGPD1 ZZZ3 ALMS1 RGPD3 TASOR | 1.05e-06 | 418 | 139 | 11 | 34709266 | |
| Pubmed | 1.32e-06 | 86 | 139 | 6 | 37253089 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR RANBP2 XRN2 BCORL1 EIF5A2 XRCC1 EIF5AL1 RIF1 ZZZ3 EIF5A PDS5A ZFR BOD1L1 SPEN TASOR HNRNPR | 1.47e-06 | 954 | 139 | 16 | 36373674 |
| Pubmed | RGPD4 CYLD TPR KIF13B SIN3B RANBP2 CYTH1 RGPD1 AP1B1 AP2B1 RGPD3 SYNE2 ZSCAN18 MACF1 ZFR PARD3 | 1.66e-06 | 963 | 139 | 16 | 28671696 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.16e-06 | 7 | 139 | 3 | 15710750 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 28369036 | ||
| Pubmed | SETD1A SIN3B RIF1 ZZZ3 SMARCD1 SMARCD2 SMARCD3 ZFR BOD1L1 PSME3 TOP3A | 2.27e-06 | 453 | 139 | 11 | 29656893 | |
| Pubmed | TPR RANBP2 XRN2 LARP4 RIF1 AP1B1 AP2B1 TLN1 SYNE2 MACF1 PDS5A ZFR SPEN | 2.40e-06 | 653 | 139 | 13 | 22586326 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.60e-06 | 370 | 139 | 10 | 22922362 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 TPR RANBP2 RGPD1 LARP4 EIF5AL1 AP1B1 AP2B1 RGPD3 EIF5A ZFR PSME3 SPEN | 2.92e-06 | 665 | 139 | 13 | 30457570 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR RANBP2 TBC1D15 XRN2 KRT82 ARPC1A XRCC1 RIF1 LMO7 TLN1 SYNE2 EIF5A MACF1 ZFR SPEN HNRNPR | 3.64e-06 | 1024 | 139 | 16 | 24711643 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | RALGAPA1 KLHL2 MYO9A CYTH1 DOCK9 XRCC1 LARP4 ZBTB14 RIF1 ERGIC3 AP1B1 TLN1 SMARCD3 RPGR VPS28 | 4.80e-06 | 925 | 139 | 15 | 28986522 |
| Pubmed | RGPD4 KIF13B RANBP2 RGPD1 ANKLE2 AP2B1 LMO7 SH3PXD2A RGPD3 SYNE2 ANKRD30A NAV2 MACF1 SMARCD2 ZFR BOD1L1 SPEN TASOR HNRNPR | 5.04e-06 | 1442 | 139 | 19 | 35575683 | |
| Pubmed | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. | 5.37e-06 | 29 | 139 | 4 | 15525990 | |
| Pubmed | RALGAPA1 TPR RANBP2 TBC1D15 MYO9A ANKLE2 CLCC1 TLN1 EIF5A MACF1 PDS5A BOD1L1 PARD3 | 5.75e-06 | 708 | 139 | 13 | 39231216 | |
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 6.18e-06 | 112 | 139 | 6 | 24390342 | |
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 34716243 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 12383505 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.16e-06 | 332 | 139 | 9 | 32786267 | |
| Pubmed | 9.87e-06 | 340 | 139 | 9 | 24332808 | ||
| Pubmed | TPR XRN2 VWA8 AP2B1 TLN1 NAV2 SMARCD1 MACF1 SMARCD2 PDS5A SMARCD3 HNRNPR | 9.88e-06 | 634 | 139 | 12 | 34591612 | |
| Pubmed | RALGAPA1 CYLD ALMS1 AP1B1 LMO7 SH3PXD2A SMARCD1 PARD3 RASSF4 TRAPPC9 | 1.33e-05 | 446 | 139 | 10 | 24255178 | |
| Pubmed | 1.34e-05 | 12 | 139 | 3 | 33723076 | ||
| Pubmed | 1.46e-05 | 37 | 139 | 4 | 24335282 | ||
| Pubmed | CYLD SPATA7 AFF2 CLCC1 RIF1 FAT1 PDS5A ZFR PSME3 RPGR PARD3 SPEN TASOR | 1.54e-05 | 777 | 139 | 13 | 35844135 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37047039 | ||
| Pubmed | BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A. | 1.59e-05 | 2 | 139 | 2 | 38989615 | |
| Pubmed | Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation. | 1.59e-05 | 2 | 139 | 2 | 31130465 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17428459 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17707773 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12894223 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29092888 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29533498 | ||
| Pubmed | Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. | 1.59e-05 | 2 | 139 | 2 | 37743008 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38423356 | ||
| Pubmed | Independent roles of eIF5A and polyamines in cell proliferation. | 1.59e-05 | 2 | 139 | 2 | 15377278 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2492279 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12079280 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37653021 | ||
| Pubmed | Identification of a new member of the human eIF-5A gene family. | 1.59e-05 | 2 | 139 | 2 | 7622067 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8253832 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3095320 | ||
| Pubmed | Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). | 1.59e-05 | 2 | 139 | 2 | 11742107 | |
| Interaction | ACTC1 interactions | TPR KLHL2 GC FBXO30 KPTN RIF1 ZZZ3 LMO7 TLN1 SYNE2 EIF5A SMARCD1 SMARCD2 SMARCD3 ZFR BOD1L1 PSME3 | 4.49e-06 | 694 | 136 | 17 | int:ACTC1 |
| Interaction | RGPD4 interactions | 1.32e-05 | 22 | 136 | 4 | int:RGPD4 | |
| Interaction | RGPD1 interactions | 1.95e-05 | 49 | 136 | 5 | int:RGPD1 | |
| Interaction | NUP50 interactions | SETD1A RANBP2 AP2B1 ZSCAN18 SMARCD1 SMARCD2 SMARCD3 ZFR BOD1L1 PSME3 SPEN | 2.05e-05 | 341 | 136 | 11 | int:NUP50 |
| Interaction | RGPD2 interactions | 3.09e-05 | 27 | 136 | 4 | int:RGPD2 | |
| GeneFamily | Protein tyrosine phosphatases type IVA | 6.38e-05 | 3 | 84 | 2 | 899 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.27e-04 | 4 | 84 | 2 | 1145 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.97e-04 | 115 | 84 | 5 | 769 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 7.52e-04 | 9 | 84 | 2 | 1280 | |
| GeneFamily | T-boxes | 3.11e-03 | 18 | 84 | 2 | 766 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 CYLD TPR FNBP1 RANBP2 XRN2 CYTH1 DOCK9 KMT2E ANKLE2 INO80D RGS2 TGFBR3 PTP4A2 RIF1 TRANK1 TLN1 MACF1 PDS5A PCNX1 ZFR BOD1L1 SPEN FYB1 TASOR MYBL1 | 7.33e-08 | 1492 | 139 | 26 | M40023 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 8.22e-07 | 33 | 139 | 5 | MM477 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_DN | ACVR2A PPP1R14B SLC16A6 MTF1 PITPNA PSME3 SPEN ZNF614 HNRNPR | 1.17e-06 | 198 | 139 | 9 | M9530 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 CYTH1 DOCK9 LARP4 ANKLE2 TGFBR3 RIF1 FAT1 ZZZ3 SYNE2 MACF1 PDS5A RPGR PARD3 SPEN TASOR MYBL1 | 3.08e-06 | 856 | 139 | 17 | M4500 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 3.19e-06 | 43 | 139 | 5 | MM3857 | |
| Coexpression | GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN | 4.50e-06 | 175 | 139 | 8 | M7101 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | RALGAPA1 PIK3AP1 FNBP1 VWA8 CP KMT2E ANKLE2 PPP1R14B RGS2 EIF5AL1 PTP4A3 TLN1 LPL EIF5A VPS28 | 7.27e-06 | 723 | 139 | 15 | MM3672 |
| Coexpression | PGF_UP.V1_UP | 8.24e-06 | 190 | 139 | 8 | M2674 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 1.11e-05 | 198 | 139 | 8 | M9534 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.11e-05 | 198 | 139 | 8 | M7948 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN | 1.20e-05 | 200 | 139 | 8 | M5364 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_LATE_UP | 1.41e-05 | 98 | 139 | 6 | M2026 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.10e-05 | 180 | 139 | 7 | M8239 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 8.72e-05 | 196 | 139 | 7 | M5862 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 9.00e-05 | 197 | 139 | 7 | M7921 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 9.59e-05 | 199 | 139 | 7 | M7498 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN | 9.59e-05 | 199 | 139 | 7 | M8721 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 9.59e-05 | 199 | 139 | 7 | M4494 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_UP | 9.59e-05 | 199 | 139 | 7 | M3078 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 9.89e-05 | 200 | 139 | 7 | M4659 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 9.89e-05 | 200 | 139 | 7 | M8042 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 9.89e-05 | 200 | 139 | 7 | M7500 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 9.89e-05 | 200 | 139 | 7 | M7786 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500 | 2.64e-05 | 91 | 136 | 6 | gudmap_developingGonad_e12.5_ovary_k5_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_200 | 4.07e-05 | 2 | 136 | 2 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SETD1A KLHL2 MGAM TBC1D15 COL11A1 KMT2E LARP4 RGS2 FBXO30 RIF1 SYNE2 NAV2 PSME3 RPGR MYBL1 HNRNPR | 5.80e-05 | 804 | 136 | 16 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | SETD1A KLHL2 MGAM KMT2E FBXO30 RIF1 SYNE2 PSME3 RPGR MYBL1 HNRNPR | 7.95e-05 | 417 | 136 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SETD1A TBC1D15 TPRA1 DOCK9 LARP4 RGS2 RIF1 LMO7 SYNE2 NAV2 RPGR PARD3 IL17RB MYBL1 HNRNPR | 1.27e-04 | 770 | 136 | 15 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.31e-04 | 233 | 136 | 8 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | CYLD SETD1A TBC1D15 MYO9A KMT2E LARP4 RGS2 FBXO30 RIF1 ALMS1 SYNE2 NAV2 RPGR MYBL1 HNRNPR | 1.38e-04 | 776 | 136 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SETD1A KLHL2 MGAM COL11A1 AFF3 BCORL1 KMT2E RIF1 TLN1 SYNE2 NAV2 ZFR GAREM1 MYBL1 HNRNPR | 1.68e-04 | 790 | 136 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | SETD1A TBC1D15 RIF1 LMO7 SYNE2 RPGR PARD3 IL17RB MYBL1 HNRNPR | 1.69e-04 | 379 | 136 | 10 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 1.74e-04 | 81 | 136 | 5 | GSM538234_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.82e-04 | 311 | 136 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 RANBP2 RTN3 ACVR2A EPB41L4A LARP4 CLCC1 RIF1 NELL2 ALMS1 SYNE2 NAV2 PDS5A CCDC25 BOD1L1 RPGR MYBL1 | 1.99e-04 | 989 | 136 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.46e-04 | 136 | 136 | 6 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.66e-04 | 138 | 136 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.82e-04 | 404 | 136 | 10 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RALGAPA1 RANBP2 MYO9A RTN3 ACVR2A EPB41L4A INO80D CLCC1 RIF1 ALMS1 CGRRF1 SYNE2 PDS5A BOD1L1 MYBL1 | 2.88e-04 | 831 | 136 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 3.10e-04 | 409 | 136 | 10 | gudmap_developingGonad_e12.5_ovary_500 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-09 | 176 | 139 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 6.51e-09 | 183 | 139 | 9 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.89e-08 | 177 | 139 | 8 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.89e-08 | 177 | 139 | 8 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.89e-08 | 177 | 139 | 8 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.89e-08 | 177 | 139 | 8 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.89e-08 | 177 | 139 | 8 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 191 | 139 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 191 | 139 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 191 | 139 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.02e-07 | 197 | 139 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.12e-07 | 156 | 139 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 7.89e-07 | 162 | 139 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-07 | 167 | 139 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-06 | 171 | 139 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 184 | 139 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 185 | 139 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 185 | 139 | 7 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.13e-06 | 188 | 139 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-06 | 188 | 139 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.13e-06 | 188 | 139 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.45e-06 | 192 | 139 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.54e-06 | 193 | 139 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.72e-06 | 195 | 139 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.72e-06 | 195 | 139 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.81e-06 | 196 | 139 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.90e-06 | 197 | 139 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-06 | 197 | 139 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.00e-06 | 198 | 139 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 3.10e-06 | 199 | 139 | 7 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.21e-06 | 200 | 139 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.21e-06 | 200 | 139 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.20e-05 | 162 | 139 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 167 | 139 | 6 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 167 | 139 | 6 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 167 | 139 | 6 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 169 | 139 | 6 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-05 | 171 | 139 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | 3f796d53d3110e5d6e97de53bb49d323944659d6 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | d9fbc2b00dbf9dddc95d9a20d804459a9ebd1820 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | e77bfc925d73ccffe3c8cfb13764e70579a7f942 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 175 | 139 | 6 | 16cf0c5d3d009480e07e8fe78c0f8555c2d6e3df | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 175 | 139 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 177 | 139 | 6 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 178 | 139 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 178 | 139 | 6 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 178 | 139 | 6 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 179 | 139 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-05 | 180 | 139 | 6 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-05 | 180 | 139 | 6 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 181 | 139 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.25e-05 | 181 | 139 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.32e-05 | 182 | 139 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-05 | 182 | 139 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 182 | 139 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 182 | 139 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 182 | 139 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.39e-05 | 183 | 139 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.39e-05 | 183 | 139 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-05 | 183 | 139 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 184 | 139 | 6 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 184 | 139 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-05 | 184 | 139 | 6 | c451acfcd8fe28c1f4b1ea334b1129fa84a15c42 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 184 | 139 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.47e-05 | 184 | 139 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 185 | 139 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 185 | 139 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.54e-05 | 185 | 139 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 2.62e-05 | 186 | 139 | 6 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.62e-05 | 186 | 139 | 6 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 186 | 139 | 6 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-05 | 186 | 139 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 186 | 139 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 187 | 139 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 2.70e-05 | 187 | 139 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 187 | 139 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 187 | 139 | 6 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-05 | 188 | 139 | 6 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.87e-05 | 189 | 139 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-05 | 189 | 139 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.87e-05 | 189 | 139 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.95e-05 | 190 | 139 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-05 | 190 | 139 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 191 | 139 | 6 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-05 | 191 | 139 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.04e-05 | 191 | 139 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.13e-05 | 192 | 139 | 6 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.13e-05 | 192 | 139 | 6 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.32e-06 | 197 | 138 | 9 | 1071_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.32e-06 | 197 | 138 | 9 | 3006_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 3.32e-06 | 197 | 138 | 9 | 5770_DN | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; HL60; HG-U133A | TPRA1 BCORL1 ANKLE2 PTP4A3 ALMS1 PCNX1 RASSF4 TRAPPC9 HNRNPR | 3.46e-06 | 198 | 138 | 9 | 1407_DN |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.60e-06 | 199 | 138 | 9 | 3345_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.30e-05 | 192 | 138 | 8 | 4268_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 1536_UP | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; HL60; HG-U133A | 2.77e-05 | 197 | 138 | 8 | 1992_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 2103_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 3187_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 4265_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 3356_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 2057_UP | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 2135_DN | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; HL60; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 1265_DN | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 7.04e-06 | 9 | 131 | 3 | DOID:1925 (implicated_via_orthology) | |
| Disease | Headache, HOMA-IR | 1.17e-04 | 4 | 131 | 2 | EFO_0004501, HP_0002315 | |
| Disease | Intellectual Disability | 1.80e-04 | 447 | 131 | 9 | C3714756 | |
| Disease | rheumatoid arthritis | 2.29e-04 | 462 | 131 | 9 | EFO_0000685 | |
| Disease | neuroimaging measurement | SPATA7 KIF6 COL11A1 DOCK9 AFF3 RGPD1 LARP4 PGM1 FZD9 NELL2 SH3PXD2A NAV2 MACF1 PARD3 | 2.95e-04 | 1069 | 131 | 14 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | KIF6 COL11A1 BCORL1 RGS2 EOMES RIF1 UNC45B SYNE2 ANKRD30A SMARCD1 MACF1 BOD1L1 SPEN HNRNPR | 3.09e-04 | 1074 | 131 | 14 | C0006142 |
| Disease | PR interval | 3.80e-04 | 495 | 131 | 9 | EFO_0004462 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 4.63e-04 | 34 | 131 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | triacylglycerol 52:4 measurement | 5.49e-04 | 36 | 131 | 3 | EFO_0010416 | |
| Disease | Paroxysmal atrial fibrillation | 6.75e-04 | 156 | 131 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 6.75e-04 | 156 | 131 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.75e-04 | 156 | 131 | 5 | C2585653 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 6.90e-04 | 9 | 131 | 2 | C4225275 | |
| Disease | Atrial Fibrillation | 7.56e-04 | 160 | 131 | 5 | C0004238 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 9.93e-04 | 170 | 131 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.06e-03 | 45 | 131 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 1.19e-03 | 702 | 131 | 10 | C0009402 | |
| Disease | blood copper measurement | 1.44e-03 | 50 | 131 | 3 | EFO_0007578 | |
| Disease | colitis (implicated_via_orthology) | 1.48e-03 | 13 | 131 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | Abnormality of chromosome segregation | 2.43e-03 | 60 | 131 | 3 | HP_0002916 | |
| Disease | serum gamma-glutamyl transferase measurement | PIK3AP1 MYO9A CYTH1 EIF5A2 PGM1 FZD9 TRANK1 ZZZ3 TLN1 NAV2 PARD3 | 2.58e-03 | 914 | 131 | 11 | EFO_0004532 |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.80e-03 | 63 | 131 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | Myeloid Leukemia | 2.86e-03 | 18 | 131 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.86e-03 | 18 | 131 | 2 | C0023466 | |
| Disease | Headache | 2.92e-03 | 64 | 131 | 3 | HP_0002315 | |
| Disease | Seizures | 2.95e-03 | 218 | 131 | 5 | C0036572 | |
| Disease | Global developmental delay | 2.97e-03 | 133 | 131 | 4 | C0557874 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | emphysema pattern measurement | 3.18e-03 | 19 | 131 | 2 | EFO_0005850 | |
| Disease | brain measurement, neuroimaging measurement | 3.24e-03 | 550 | 131 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | FEV/FEC ratio | MGAM TPRA1 CAMK1D DOCK9 AFF3 TGFBR3 NELL2 FBN1 SH3PXD2A SYNE2 NAV2 PARD3 TBX5 | 3.27e-03 | 1228 | 131 | 13 | EFO_0004713 |
| Disease | Retinal Degeneration | 3.89e-03 | 21 | 131 | 2 | C0035304 | |
| Disease | hemorrhoid | 4.25e-03 | 147 | 131 | 4 | EFO_0009552 | |
| Disease | Leber Congenital Amaurosis | 4.26e-03 | 22 | 131 | 2 | C0339527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKCDNEDDYREIKKS | 821 | P51826 | |
| PSIKCEDINAEEYSK | 656 | O95936 | |
| SRNKYDKTPEDVICE | 441 | Q86XL3 | |
| KDEDPYVRKTAAVCV | 131 | P63010 | |
| SDKNNPDVCDEYKRT | 141 | Q15327 | |
| RRDCKADVDTKPAYQ | 56 | Q8IYS8 | |
| CTATELYQAVEKAKP | 446 | P51816 | |
| YDRTDCVEKKDSPEV | 86 | P27037 | |
| KTCRIAAKPYEEQVN | 906 | Q5H9F3 | |
| SVDELKIPKDCDRYD | 326 | Q8TCU4 | |
| RADEILPSESKQKDY | 666 | Q9BXX3 | |
| KDEDPYVRKTAAVCV | 131 | Q10567 | |
| CDDEPETYVAAVKKA | 126 | Q6ZUJ8 | |
| CRVFSAYIKEVDEKP | 166 | Q92747 | |
| ATPSFEDLVEKYCEK | 361 | Q7Z5Q5 | |
| SKTIEEYAVCPDLKV | 151 | P36871 | |
| PEEQEECKNYLRKTR | 701 | P49792 | |
| PDESKTNEKLYTVCD | 1066 | Q29RF7 | |
| ESGERTKLKDCEYPL | 226 | Q9H2L5 | |
| RSQVLSKDYKAEEDP | 146 | Q00169 | |
| IKTYCSEPEKVDKDN | 236 | P00450 | |
| DYDTKVVDLDPCLSK | 4331 | Q14517 | |
| IDCNKIYERVVEKPS | 166 | Q99435 | |
| IDIFTGKKYEDICPS | 61 | Q9GZV4 | |
| SIKIRDEEKIDCYPD | 1851 | O43451 | |
| IDTKDDYNALSVCPK | 451 | Q9NRM6 | |
| ETCIYPDKKSEGVRI | 1646 | P12107 | |
| DPNTCEVNTKYKAVR | 216 | Q8IZT8 | |
| EYCSSRRAKPVDVDK | 1771 | Q96RV3 | |
| AKETKDRPLQDEYSV | 261 | Q9Y664 | |
| NEENPSKAYRCSSKE | 281 | P06858 | |
| RPIYEEDLKKCVTAD | 1171 | Q02817 | |
| DAYPKTLEDFRVKTC | 11 | Q9Y282 | |
| YPCNRVKTDSVDLKS | 596 | Q9H706 | |
| TDDTKVLCRNEEGKY | 741 | O15117 | |
| EAVKLCDSYEIRPGK | 221 | O43390 | |
| SKINYSQCEPILDDK | 91 | Q13324 | |
| SQCEPILDDKQRKYD | 96 | Q13324 | |
| SIREVEDSKKPNCFE | 311 | Q15438 | |
| DCQEPLKEEEYRKLR | 451 | Q6ZMV9 | |
| IKSDDETCRNGYKPI | 916 | Q8IZD2 | |
| NKDAYRPTTDADKIE | 3236 | O94854 | |
| CYLEEEKAKTRSIPN | 381 | Q8WWI1 | |
| IDIFTGKKYEDICPS | 61 | P63241 | |
| KTECYSFERIKSPEV | 236 | Q8N5I3 | |
| KKYEEELSLRPCVEN | 206 | Q9NSB4 | |
| TKVERFPDLAAEKEC | 136 | Q86WR0 | |
| YPDREDCTTEKGKKT | 2056 | Q9UPN3 | |
| HLLEKDPNERYTCEK | 256 | Q96NX5 | |
| IYRIDEKSLDESKNP | 371 | Q7RTM1 | |
| SPEEQEECKNYLRKT | 701 | A6NKT7 | |
| APKCEQDLTIKNDYS | 2596 | Q8NFC6 | |
| EPESSSYQENCRKRK | 86 | A6NGY1 | |
| CENPEKFQYVEKSRS | 196 | O00144 | |
| KLEPLTSDDSDNYKC | 126 | Q8N9C0 | |
| IDIFTGKKYEDICPS | 61 | Q6IS14 | |
| PKSYCLENEEAVRKI | 566 | Q9NVR0 | |
| KDSDEEDSQPLKCIY | 671 | Q9BZ29 | |
| VPTSYVEVCLDKNAK | 601 | Q96RU3 | |
| FIYKPDLKTCEDIDE | 796 | P35555 | |
| ETRKQTACKPEIAYA | 1546 | P01031 | |
| VYKEKDNEELTISCP | 511 | Q71RC2 | |
| LEDKTAPFKQCEYVA | 41 | Q53TQ3 | |
| CALNKSSEFKEVPER | 86 | Q00978 | |
| DKYPKEDSEIRCLSQ | 21 | P50053 | |
| SLNDCFKKVPRDEDD | 176 | Q12951 | |
| ECYDDPDISAGKIKQ | 801 | Q9NQC7 | |
| KCSYNVVEKREEAIP | 706 | Q8TB52 | |
| CKAYSPEDLEERKNS | 91 | Q8WXD5 | |
| SKEEIYCQLPRDTKI | 146 | Q99675 | |
| EDPCKLKEEITRYQF | 101 | Q9HCS5 | |
| RRTYTEDPKESIKQC | 1346 | Q96RY7 | |
| LKEEDEPAYKSCKQE | 601 | P10243 | |
| RAAIDKSYDKPAVDD | 926 | Q8TEW0 | |
| FPEEQEECKNYLRKT | 691 | P0DJD0 | |
| EALVDCYKPTEEFIK | 131 | Q8TAE6 | |
| LKLCSKANVYTEVPD | 6 | O15403 | |
| YDFKCDRLSEIPEEK | 781 | Q92834 | |
| KECEEDNPVIRSYFK | 771 | Q9NQT8 | |
| EIPSCEREEKTSKNF | 541 | O95197 | |
| SPEEQEECKNYLRKT | 701 | Q7Z3J3 | |
| ESEFYQDLCKKPQIT | 191 | P41220 | |
| DKTEKPCLLSEYTEN | 26 | Q8IYX7 | |
| PNDQKKTACYDIDVE | 381 | Q96GM5 | |
| CLTPELSELKKQYES | 1806 | Q8WXH0 | |
| RKEEECSTTDHPYKK | 326 | Q99593 | |
| LPNVCEEKNETSKYA | 1646 | Q5UIP0 | |
| QSECPETKRKEVKRY | 126 | Q14872 | |
| VYSTPEEKCQSEIRK | 1681 | Q8IVL1 | |
| SVDPSDQKKTACYDI | 346 | Q6STE5 | |
| KKTPYEEQLHRCEDE | 476 | O75182 | |
| LKSSKAPAYVRDCVE | 506 | Q9Y4R8 | |
| KHYEAKPDCEERTLE | 361 | Q13972 | |
| EKDKYLDVCPVSARQ | 1506 | O15047 | |
| EKDPNKRYTCEQAAR | 261 | Q8IU85 | |
| ARVKELLVDCYKPTE | 111 | Q96C90 | |
| DPNDQKKTACYDIDV | 396 | Q92925 | |
| KKTACYDIDVEVDDP | 401 | Q92925 | |
| DKKDYEQPTCAKVEN | 821 | Q9UK61 | |
| REKMYSEPKSEEETC | 431 | O75969 | |
| DCSTKSKEEPYVLAV | 336 | Q7Z7G1 | |
| PASKENEEKVCLEYN | 71 | Q9BW66 | |
| CEKKKREDYESQSNP | 81 | Q96S66 | |
| FDELKTDYKNPIDQC | 31 | O95406 | |
| GPTYKKRRLDECEEA | 81 | P61289 | |
| CKEYVEDLAKIPRSF | 71 | Q7RTV5 | |
| RKICEEYITGKFDPQ | 376 | Q8IWX7 | |
| AEENFSRSYPCDEKK | 26 | Q9NR97 | |
| SRSYPCDEKKQNDSV | 31 | Q9NR97 | |
| SEPKILFSYKCQVDE | 286 | Q86W33 | |
| DKLCSQKRDVSSPDE | 121 | O43829 | |
| VRVCEVTYDKTPLEK | 46 | O75365 | |
| ETNEAIYCTKEPFIK | 286 | Q6GYQ0 | |
| KNYCSLRDETPERKS | 1131 | Q96T58 | |
| QKDPDTEEYRKLLSE | 1346 | P12270 | |
| IDTPKCNLLYSKDTE | 186 | Q9BQR3 | |
| PSDAYTKKELIECAR | 1941 | Q9Y490 | |
| RPVEDKKRYENTDSD | 241 | C9JQI7 | |
| CDATYDKAPVEKEGI | 46 | Q12974 | |
| ASESQDSPRKLKYEE | 541 | Q5TCZ1 | |
| PSEDINLDIKYKERS | 576 | Q8IV35 | |
| SRKYPSIIVNCVEEK | 11 | Q9H0D6 | |
| QKINAREKPYECEEC | 161 | Q96SK3 | |
| RQAKDPECKTEDFVS | 2211 | Q6ZS81 | |
| ALEKAYIKDCVSPSE | 51 | Q9UK41 | |
| NDEICEAFRKDPKEY | 141 | P02774 | |
| SNCVTYDAKEKIAPL | 306 | Q9P0W8 | |
| VYVKVKSAEPADCAE | 86 | P0DPA3 | |
| SLEKYVVLCESPQDK | 176 | Q8TC07 | |
| YCPENFVDIKKTLER | 121 | Q13472 | |
| SPEKYDIKCAVSEAA | 836 | Q96KR1 | |
| AQYPESCKKAASLVE | 111 | Q8TBC5 | |
| DRVKIVCSQPYSKDS | 126 | P18887 | |
| NCLSPEDIIDKYKEA | 316 | Q96Q05 | |
| HQRIRTEEKPYKCEE | 381 | Q9NSJ1 | |
| KTNTTDKICIPNEYR | 251 | Q8N883 | |
| KRIPRCYVEDTEAEK | 946 | O15050 | |
| TDDNLEPELKDYKCE | 711 | A3KMH1 | |
| EPELKDYKCEVTSGT | 716 | A3KMH1 | |
| SKPRENKDVLAFTCE | 156 | Q15238 | |
| RKEDSYIDHKVPCTD | 256 | Q8IYH5 | |
| IENICPKDESVKFYS | 656 | Q03167 | |
| APKAIRSVECYDFKE | 316 | O95198 | |
| KKTYRDDSIDICNPE | 436 | B2RTY4 |